Browsing Tag
tROPhy-1 study
1 post
FDA grants FELIQS fast track status for FLQ-101 in ROP preventive treatment
FELIQS, a multinational clinical-stage biopharmaceutical firm headquartered in Japan, has announced that its leading asset, FLQ-101, has received…